Based on our findings, SDOs can reduce the deterioration effect of diabetes through a variety of mechanisms, including stimulating insulin secretion from beta cells, aiding in beta-cell recovery, and increasing the number of beta cells. The gene discussed is INS; the disease is diabetes mellitus.